APA (7th ed.) Citation

I, B., PA, C., S, M., CA, E., OC, F., B, N., . . . TH, D. (2025). Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy. NPJ precision oncology, 10(1), 1. https://doi.org/10.1038/s41698-025-01182-3

Chicago Style (17th ed.) Citation

I, Bishara, et al. "Divergent Oncogenic Signaling and Immune Microenvironment Changes in Low-grade Serous Ovarian Cancer Patients Undergoing Intraperitoneal Chemotherapy." NPJ Precision Oncology 10, no. 1 (2025): 1. https://doi.org/10.1038/s41698-025-01182-3.

MLA (9th ed.) Citation

I, Bishara, et al. "Divergent Oncogenic Signaling and Immune Microenvironment Changes in Low-grade Serous Ovarian Cancer Patients Undergoing Intraperitoneal Chemotherapy." NPJ Precision Oncology, vol. 10, no. 1, 2025, p. 1, https://doi.org/10.1038/s41698-025-01182-3.